CNSX:RQB Ravenquest Biomed (RQB) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free RQB Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Ravenquest Biomed alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Ravenquest Biomed Stock (CNSX:RQB)RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.Read More Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. RQB Stock News HeadlinesSeptember 4, 2023 | investing.comTA Biomed Technical AnalysisJune 7, 2023 | finance.yahoo.comFluid Biomed Inc. Announces World's First Implantation of Polymer-based Neurovascular Stent in Human PatientsApril 30, 2024 | PharmaStocksToday (Ad)NYSE Spotlight & A Soaring Biotech Breakthrough You Need to SeeThe CEO of a groundbreaking biotech firm we’ve been closely following made headlines with a stunning appearance on the NY Stock Exchange floor, unveiling news that's too big to ignore. But here’s why this matters to you: in the world of investing, timing is everything. March 22, 2023 | finance.yahoo.comHarbour BioMed Announces Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia GravisMarch 20, 2023 | startribune.comWith declining revenue, Chaska biomedical company looking at 'strategic alternative'March 18, 2023 | seekingalpha.comOrchestra BioMed Holdings (OBIO) Investor Presentation - SlideshowFebruary 23, 2023 | seekingalpha.comOBIO Orchestra BioMed Holdings, Inc.February 23, 2023 | benzinga.comTricol Biomedical Expands IP Protection with First New Patent for Gastrointestinal HemostasisApril 30, 2024 | PharmaStocksToday (Ad)NYSE Spotlight & A Soaring Biotech Breakthrough You Need to SeeThe CEO of a groundbreaking biotech firm we’ve been closely following made headlines with a stunning appearance on the NY Stock Exchange floor, unveiling news that's too big to ignore. But here’s why this matters to you: in the world of investing, timing is everything. October 26, 2022 | finance.yahoo.comHarbour BioMed Announces Dosing of First Patient in Phase I Trial of B7H4x4-1BB Bispecific Antibody in the United StatesSeptember 21, 2022 | money.usnews.comBiomedical Engineer SalarySeptember 17, 2022 | finance.yahoo.comHarbour BioMed Announces 2022 Interim ResultsSee More Headlines Receive RQB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ravenquest Biomed and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCNSX:RQB CUSIPN/A CIKN/A Webwww.rqbglobal.com Phone604-484-1230FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. W. George RobinsonCEO, Pres & DirectorMs. Marla K. Ritchie (Age 56)Corp. Sec. Key CompetitorsAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJBio-Rad LaboratoriesCNSX:BIOBlueberries MedicalCNSX:BBMView All Competitors RQB Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Ravenquest Biomed own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ravenquest Biomed investors own include Aurora Cannabis (ACB), Hydropothecary (THCX), Canopy Growth (WEED), ICC Labs (ICC), Cannabix Technologies (BLO), Cross Timbers Royalty Trust (CRT), FSD Pharma (HUGE) and Leaf Mobile (LEAF). How do I buy shares of Ravenquest Biomed? Shares of RQB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:RQB) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersTruth about Trump you’ve never heardPorter & CompanyBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ravenquest Biomed Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
